DTaP vs Tdap Vaccine

If you received a DTaP or Tdap vaccine and developed a serious health condition in the weeks or months that followed, you may have a legal claim. Vaccines containing tetanus toxoid are covered under the National Vaccine Injury Compensation Program, and several serious injuries have been associated with this vaccine type. What’s most important isn’t the difference between DTaP vs Tdap vaccine administration, but instead the symptoms you developed after, when they developed, how they affected your life, and the degree to which you are able to document all aspects of your claim.

At Sadaka Law, we have represented more than 450 vaccine injury clients over more than 20 years of VICP practice. Tetanus-containing vaccines are among the most frequently filed vaccine injury claim categories in the program, and our firm has considerable experience representing people who sustained a DTaP/Tdap vaccine injury.

We are ready to help you understand whether your situation supports a claim and how to proceed, whether that means a more straightforward on-table claim or a highly complex off-table claim. Fill out our online contact form today, and get started with a free case review.

DTaP vs Tdap Vaccine: Understanding the Difference and Why It Matters

DTaP and Tdap are related but distinct vaccines, and the difference between them affects who receives them, when, and in what context. Understanding which vaccine you received, DTaP vs Tdap vaccine vs other tetanus toxoid vaccinations, is an important first step in evaluating a potential injury claim.

The DTaP Vaccine: Childhood Protection Against Three Serious Diseases

DTaP stands for diphtheria, tetanus, and acellular pertussis. It is the childhood series vaccine, administered to children under age seven in a series of five doses, typically at two months, four months, six months, between 15 and 18 months, and again between four and six years. The capital letters in the name reflect the relative dosing: a capital D indicates a full-strength diphtheria component, and a capital P indicates a full-strength pertussis component.

The Tdap Vaccine: The Adult and Adolescent Booster

Tdap is the booster formulation of the same three-disease vaccine. The lowercase letters reflect a lower-dose diphtheria and pertussis component designed for adolescents and adults whose immunity from the childhood DTaP series has waned over time. Tdap is routinely recommended at age 11 or 12, and a single Tdap dose is recommended for adults who have never received it. It is also recommended during every pregnancy, typically between 27 and 36 weeks, to protect newborns before they are old enough to begin their own vaccine series.

Other Tetanus Vaccines

Beyond DTaP and Tdap, there are additional tetanus-containing vaccine formulations. Td contains only tetanus and diphtheria components without pertussis, and is used in specific situations such as wound management in adults or for patients with a history of adverse reactions to the pertussis component. TT is a standalone tetanus toxoid vaccine. All of these vaccines contain tetanus toxoid and share the Table injuries associated with that component. Vaccines that also contain pertussis antigens, including DTaP and Tdap, may have an additional applicable Table provision.

Why the DTaP vs Tdap Vaccine Distinction Matters for Your Claim

Why does the DTap vs Tdap vaccine distinction matter for a VICP claim? The vaccine you received affects your medical record documentation requirements, the population context your attorney works within, and, in some cases, the causation arguments available.

An adult who received Tdap at a pharmacy during a routine physical has a different documentation challenge than a parent who received it during a prenatal visit or a child who received DTaP as part of the childhood schedule. Knowing which vaccine you received, as well as when and where it was administered, is the starting point for a well-built petition.

Injuries Associated With DTaP and Tdap Vaccine Injury Claims

Tetanus-containing vaccines have been associated with a range of serious injuries, both on-table and off-table. The following conditions are among the vaccine injuries that our firm handles most frequently in connection with DTap, Tdap, and other tetanus vaccines.

Brachial Neuritis

Brachial neuritis, also known as Parsonage-Turner Syndrome, is the most directly associated on-Table injury for tetanus-containing vaccines. It causes sudden, severe pain in the shoulder and upper arm, followed by weakness and numbness that can persist for months or years. It is listed on the Vaccine Injury Table for tetanus-containing vaccines when symptoms first appear between two and 28 days after vaccination. Our firm has secured multiple results for clients who developed brachial neuritis after Tdap vaccination.

SIRVA (Shoulder Injury Related to Vaccine Administration)

SIRVA is an injury associated with vaccine administration that may occur when unintended injection of vaccine antigen or needle trauma affects the structures in and around the shoulder bursa rather than remaining properly placed in the deltoid muscle. Improper placement, including an injection given too high on the arm, may contribute to the injury. SIRVA is listed on the Vaccine Injury Table for intramuscular injections, including DTaP and Tdap, when symptoms begin within 48 hours of vaccination. SIRVA is one of the most commonly filed VICP injuries overall. A SIRVA after DTaP vaccination claim requires careful early documentation.

Anaphylaxis

Anaphylaxis is a severe, potentially life-threatening allergic reaction that can occur within minutes of receiving a vaccine. It is listed on the Vaccine Injury Table for tetanus-containing vaccines when it occurs within four hours of administration.

Vasovagal Syncope

Vasovagal syncope is a fainting episode triggered by the body's stress response to the vaccination. It is listed on the Vaccine Injury Table for tetanus-containing vaccines when it occurs within one hour of administration. While a brief fainting episode alone may not meet the VICP's severity threshold, vasovagal syncope that results in a fall and a serious secondary injury, such as a head injury or fracture, can qualify for compensation.

Guillain-Barré Syndrome (GBS)

Guillain-Barré Syndrome (GBS) is a neurological condition in which the immune system attacks the peripheral nervous system, causing progressive weakness that can, in serious cases, result in temporary paralysis. It is listed on the Vaccine Injury Table for the seasonal flu vaccine but not for tetanus-containing vaccines. GBS following DTaP or Tdap is pursued as an off-table claim, requiring medical and scientific evidence establishing causation.

Transverse Myelitis

Transverse myelitis is an inflammatory condition affecting the spinal cord that can cause weakness, sensory changes, and, in severe cases, significant loss of mobility. It has been reported following tetanus-containing vaccines and is typically pursued as an off-table VICP claim.

ADEM (Acute Disseminated Encephalomyelitis)

Acute disseminated encephalomyelitis (ADEM) is a sudden, widespread inflammatory attack on the brain and spinal cord. It has been associated with several covered vaccines, including tetanus-containing vaccines, and is typically pursued as an off-table claim.

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Chronic inflammatory demyelinating polyneuropathy (CIDP) is a chronic autoimmune condition affecting the myelin sheath that protects the peripheral nerves, causing progressive weakness, sensory loss, and long-term functional impairment. It has been documented in connection with DTaP and Tdap vaccines in VICP proceedings and is pursued as an off-table claim requiring medical and scientific evidence of causation.

Encephalopathy and Encephalitis

For vaccines containing pertussis antigens, including both DTaP and Tdap, encephalopathy or encephalitis is listed on the Vaccine Injury Table when it occurs within 72 hours of vaccination. This is a serious neurological condition involving inflammation or dysfunction of the brain. Vaccines without pertussis antigens, including Td and TT, do not fall within this additional pertussis-related Table provision.

Other Conditions

Tetanus-containing vaccines have been associated with additional serious adverse events in reported cases. If you developed a condition following DTaP or Tdap vaccination that does not appear on this list, a free consultation is the most reliable way to determine whether a claim may be viable.

Several of the conditions associated with DTaP and Tdap vaccination, including brachial neuritis, GBS, transverse myelitis, and ADEM, involve the immune system attacking the body's own tissues. Our firm assists clients with claims involving a range of autoimmune conditions that developed after DTap and Tdap vaccinations.

On-Table DTaP/Tdap Vaccine Injuries and Off-Table Claims

Under the National Vaccine Injury Compensation Program (VICP), claims that involve specific listed harms, with the first symptom developing within a specified timeframe, are considered on-table claims, while injuries that don’t meet these criteria would have to be pursued as off-table claims. Understanding whether your injury is an on-table or off-table matter shapes how your claim is built and what evidence is required.

For tetanus-containing vaccines, the on-Table injuries vary depending on the specific formulation received.

For all tetanus-containing vaccines, including DTaP, Tdap, DT, Td, and TT, the following conditions qualify as on-Table injuries:

  • Anaphylaxis within four hours
  • Brachial neuritis between two and 28 days
  • SIRVA within 48 hours
  • Vasovagal syncope within one hour

For vaccines that also contain pertussis antigens, including DTaP and Tdap, but not Td or TT formulations, one additional condition qualifies as an on-Table injury:

  • Encephalopathy or encephalitis within 72 hours

When your condition and timing meet the applicable Table criteria for the specific vaccine you received, causation is legally presumed. You do not need to prove that the vaccine caused your injury. The burden shifts to the government to demonstrate that something other than the vaccine was responsible.

For conditions not listed on the Table, including GBS, transverse myelitis, and ADEM following tetanus-containing vaccines, your claim requires presenting medical and scientific evidence establishing causation. These off-table claims are more complex, and they benefit significantly from legal and scientific preparation from the earliest stages of representation.

Even for on-Table injuries, the government may raise challenges based on your prior medical history, the completeness of your documentation, or the timing of your first symptom. On-table status improves your legal position significantly, but it does not eliminate the value of having experienced legal representation on your side.

Filing a DTaP/Tdap Vaccine Injury Claim: What You Need to Know

Whether your claim is on-table or off-table, building a strong VICP petition requires specific documentation. Here is what matters most for filing a VICP claim for injuries after receiving DTaP, Tdap, and other tetanus-containing vaccines.

Your Vaccination Records

Tdap is frequently administered outside a primary care setting, including at pharmacies, urgent care clinics, occupational health offices, and OB practices during prenatal visits. Records from these settings can be harder to track down than pediatric medical records, but they are equally essential. Your vaccination records need to confirm the specific vaccine you received, the date of administration, and the injection site. If you are not sure where to obtain your records, your attorney can help you identify and request them from the right sources.

Your Medical Timeline

Your records need to establish clearly when your symptoms first began relative to your vaccination date. For on-table injuries, that timing is critical. A brachial neuritis onset documented outside the two-to-28-day window, for example, changes your claim from on-table to off-table. For off-table claims, the temporal relationship between vaccination and symptom onset is one of the key components of the causation argument.

Diagnostic Records

Depending on your injury, diagnostic documentation will vary. Brachial neuritis is typically supported by nerve conduction studies and EMG testing. SIRVA is typically supported by MRI findings consistent with bursitis or rotator cuff involvement. GBS is supported by nerve conduction studies, EMG, and cerebrospinal fluid analysis. The more precisely your diagnosis is documented in your records, the stronger your petition.

The Filing Deadline

You have three years from the date of your first symptom to file a VICP petition. For acute injuries like anaphylaxis and SIRVA, that date is usually clear. For conditions like brachial neuritis, which often begins with severe pain before weakness develops, the date of the first symptom, not the first medical visit, is when the clock begins to run. Do not wait to seek legal guidance.

Our Results in DTaP and Tdap Vaccine Injury Cases

Our firm has secured meaningful results for clients who developed serious injuries following tetanus-containing vaccine administration, including:

  • $300,000 recovery for an adult male who developed Guillain-Barré Syndrome after receiving a tetanus-diphtheria (Tdap) vaccine
  • $85,000 recovery for an adult female who developed brachial neuritis, brachial plexus injury, and shoulder injury after receiving a Tdap vaccine
  • $85,000 recovery for an adult male who developed shoulder injury after receiving a Tdap vaccine
  • $70,000 recovery for an adult female who developed SIRVA after receiving a Tdap vaccine
  • $45,000 recovery for an adult male who developed Parsonage-Turner Syndrome after a Tdap vaccine

These results, along with the other recoveries we have secured for clients who suffered harm after a DTaP or Tdap vaccine, reflect a range of injury types, claim complexities, and compensation levels. Our record demonstrates the breadth of our experience with this specific vaccine family.

Why Choose Sadaka Law for Your DTaP/Tdap Vaccine Injury Claim?

Tetanus-containing vaccine injuries range from straightforward on-table matters to complex off-table claims requiring sophisticated scientific preparation. Here is what our team at Sadaka Law brings to both types of cases.

More Than 20 Years of VICP Experience, 450+ Clients Represented

Attorney Mark Sadaka has been handling VICP claims for more than 20 years and has represented more than 450 vaccine injury clients nationwide. Tetanus-containing vaccines are among the most frequently filed claim categories in the program, and our firm has handled a significant number of these cases across a range of injury types, from on-Table SIRVA and brachial neuritis claims to complex off-table neurological matters. That volume of experience means we recognize the patterns, anticipate the challenges, and know how to build these cases effectively.

Thorough Preparation for On-Table Claims

On-table claims involving brachial neuritis, SIRVA, and encephalopathy after DTaP or Tdap can be among the most clearly compensable injuries in the program, but they still require careful attention to documentation, timing, and prior medical history. A brachial neuritis onset documented outside the two-to-28-day window, a prior shoulder condition on the SIRVA side, or incomplete vaccination records can all create challenges that experienced legal guidance addresses before they become obstacles. We approach every on-table claim with the rigor it deserves, because the difference between a well-documented petition and an underprepared one is often the difference between a favorable settlement and a protracted dispute.

The Scientific and Medical Depth to Pursue Off-Table Claims

For conditions like GBS, CIDP, transverse myelitis, and ADEM following DTaP or Tdap vaccination, there is no Table presumption to rely on. The causal connection must be built from the ground up through medical records, expert analysis, and scientific literature. Attorney Mark Sadaka holds a Master of Science in Public Health with a specialization in toxicology and risk assessment, which means our team engages with the underlying science of off-table causation directly rather than delegating it entirely to outside experts. That scientific fluency strengthens how we develop causation arguments, work with medical experts, and position off-table DTaP and Tdap claims for the best possible outcome.

Clarity for Clients Who Are Confused About What Happened

Many people who receive Tdap as adults do so at a pharmacy or urgent care clinic with minimal follow-up. When something goes wrong weeks later, the connection to the vaccination is not always obvious, and the path to a legal claim may be even less so. From your first consultation, we make sure you understand exactly what may have caused your injury, whether your situation supports a claim, and what the process ahead looks like. Our team provides answers to your vaccine injury claim questions and support throughout the claims process. Clarity is one of the most important things we can offer a client navigating an unfamiliar situation.

Your DTaP/Tdap Vaccine Injury Claim Starts With a Free, No-Obligation Consultation With Sadaka Law

If you developed a serious injury after receiving a DTaP or Tdap vaccine, do not wait to find out whether you have a claim. The three-year filing deadline runs from the date of your first symptom, and an early consultation protects your rights.

Call Sadaka Law today at 201-904-3994 or fill out our online contact form. The initial case evaluation is free and confidential, with no obligation and no upfront cost, and you won’t be charged attorney fees upfront to pursue a VICP claim with Sadaka Law on your side.

Frequently Asked Questions About DTaP and Tdap Vaccine Injury Claims